Premium
Patient attitudes to topical antipsoriatic treatment with calcipotriol and dithranol
Author(s) -
Poyner Tf,
Menday Ap,
Williams Zv
Publication year - 2000
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1046/j.1468-3083.2000.00034.x
Subject(s) - dithranol , medicine , calcipotriol , dermatology , psoriasis
Objective Assessment of patient preference for antipsoriatic treatment with calcipotriol ointment or short‐contact dithranol cream. Methods Two hundred and fifty‐eight psoriatic patients treated with calcipotriol ( n = 138) or dithranol ( n = 120) for up to 3 months, assessed the acceptability of treatment, overall satisfaction with treatment, their treatment preference using the ‘willingness to pay’ principle and selected their treatment of choice. Results Overall satisfaction with calcipotriol was significantly better (72.7%, dithranol 60.3%; odds ratio 1.75, 95% CI 1.03, 2.99: P = 0.04). Patients considered calcipotriol a more acceptable treatment than dithranol in its appearance, smell, non‐irritancy, method and ease of application and lack of staining. Dithranol was considered less sticky than calcipotriol. Patients were ‘willing to pay’ a mean of £12.16 monthly for calcipotriol and £10.66 monthly for dithranol. ‘Willingness to pay’ did not correlate well with overall treatment satisfaction and was not correlated with household income. Calcipotriol was the preferred treatment of choice (calcipotriol 63%, dithranol 24%). Conclusion Patients with psoriasis prefer treatment with calcipotriol ointment over short‐contact dithranol cream.